TOURMALINE BIO INC (TRML)
US89157D1054 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to TRML. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 59.5. This target is 305.7% above the current price.
TRML was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about TRML.
In the previous month the buy percentage consensus was at a similar level.
TRML was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-25 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-03-20 | Jefferies | Maintains | Buy -> Buy |
| 2024-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-15 | Jefferies | Initiate | Buy |
| 2023-11-17 | Truist Securities | Initiate | Buy |
| 2023-10-31 | Guggenheim | Initiate | Buy |
| 2023-10-25 | Piper Sandler | Initiate | Overweight |